NCT00082524View on ClinicalTrials.gov

Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions
AspergillosisCandidiasis
Interventions
DRUG

caspofungin acetate

Duration of Treatment - 7-90 days

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00082524 - Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043) | Biotech Hunter | Biotech Hunter